ADTX — Aditxt Share News
0.000.00%
- $2.10m
- $3.24m
- $0.00m
Brief: Aditxt Provides Update On Equity Line Of Credit, ATM Usage, And Outstanding Number Of Shares
Brief: Aditxt’s Target Acquisition Appili Therapeutics Announces Results Of Special Meeting Of Shareholders
Brief: Evofem Secures Investor Support For Proposed Merger Through Voting Agreements
Brief: Aditxt’S Target Acquisition Appili Therapeutics Announces Alignment With FDA On Development Requirements For ATI-1801 Topical Antiparasitic Product NDA Submission
Brief: Appili Therapeutics Announces Alignment With FDA On Development Requirements For Ati-1801 Topical Antiparasitic Product NDA Submission
Brief: Aditxt Completes Third Parent Equity Investment Under Amended And Restated Merger Agreement With Evofem
Brief: Aditxt Announces 1-For-40 Reverse Stock Split
Brief: Aditxt Says Will Provide $1.5 Mln Of Financing By Sept 30, Additional $1.5 Mln By Oct 31
Brief: Pearsanta Submits Application Seeking To Advance Clinical Trials For Mitomic Prostate Test, Targeting Early Detection In High-Risk Patients
Brief: Aditxt Signs Second Amendment Arrangement Agreement With Appili Therapeutics
Brief: Aditxt And Evofem Amend And Restate Merger Agreement, Targeting September 30 Closing
Brief: Aditxt Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Aditxt Inc - Company Is In Default On Upsize Note And Unpaid Principal And Interest Thereon Is Due And Payable
Brief: Aditxt Announces Pricing Of $4.2 Mln Private Placement
Brief: Appili Therapeutics Signs Definitive Agreement To Be Acquired By Aditxt Inc
Brief: Aditxt Receives Correspondence From Landlord That Co Is In Default Under Agreement Of Lease
Brief: Aditxt Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies And Devices, For Telehealth And Tele-Neurology Applications
Brief: Aditxt Says Selling Stockholder Offering On A Resale Basis An Aggregate Of 3.8 Million Shares Of Common Stock
Brief: Aditxt's Subsidiary Pearsanta Acquires MDNA Life Sciences' Proprietary Mitomic Testing Platform